Wire-based antegrade dissection re-entry technique for coronary chronic total occlusions percutaneous revascularization: Experience from the ERCTO Registry.


Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139

Informations de publication

Date de publication:
11 2023
Historique:
revised: 26 07 2023
received: 14 04 2023
accepted: 24 08 2023
medline: 15 11 2023
pubmed: 5 9 2023
entrez: 5 9 2023
Statut: ppublish

Résumé

The recent development and widespread adoption of antegrade dissection re-entry (ADR) techniques have been underlined as one of the antegrade strategies in all worldwide CTO consensus documents. However, historical wire-based ADR experience has suffered from disappointing long-term outcomes. Compare technical success, procedural success, and long-term outcome of patients who underwent wire-based ADR technique versus antegrade wiring (AW). One thousand seven hundred and ten patients, from the prospective European Registry of Chronic Total Occlusions (ERCTO), underwent 1806 CTO procedures between January 2018 and December 2021, at 13 high-volume ADR centers. Among all 1806 lesions attempted by the antegrade approach, 72% were approached with AW techniques and 28% with wire-based ADR techniques. Technical and procedural success rates were lower in wire-based ADR than in AW (90.3% vs. 96.4%, p < 0.001; 87.7% vs. 95.4%, p < 0.001, respectively); however, wire-based ADR was used successfully more often in complex lesions as compared to AW (p = 0.017). Wire-based ADR was used in most cases (85%) after failure of AW or retrograde procedures. At a mean clinical follow-up of 21 ± 15 months, major adverse cardiac and cerebrovascular events (MACCEs) did not differ between AW and wire-based ADR (12% vs. 15.1%, p = 0.106); both AW and wire-based ADR procedures were associated with significant symptom improvements. As compared to AW, wire-based ADR is a reliable and effective strategy successfully used in more complex lesions and often after the failure of other techniques. At long-term follow-up, patient's MACCEs and symptoms improvement were similar in both antegrade techniques.

Sections du résumé

BACKGROUND
The recent development and widespread adoption of antegrade dissection re-entry (ADR) techniques have been underlined as one of the antegrade strategies in all worldwide CTO consensus documents. However, historical wire-based ADR experience has suffered from disappointing long-term outcomes.
AIMS
Compare technical success, procedural success, and long-term outcome of patients who underwent wire-based ADR technique versus antegrade wiring (AW).
METHODS
One thousand seven hundred and ten patients, from the prospective European Registry of Chronic Total Occlusions (ERCTO), underwent 1806 CTO procedures between January 2018 and December 2021, at 13 high-volume ADR centers. Among all 1806 lesions attempted by the antegrade approach, 72% were approached with AW techniques and 28% with wire-based ADR techniques.
RESULTS
Technical and procedural success rates were lower in wire-based ADR than in AW (90.3% vs. 96.4%, p < 0.001; 87.7% vs. 95.4%, p < 0.001, respectively); however, wire-based ADR was used successfully more often in complex lesions as compared to AW (p = 0.017). Wire-based ADR was used in most cases (85%) after failure of AW or retrograde procedures. At a mean clinical follow-up of 21 ± 15 months, major adverse cardiac and cerebrovascular events (MACCEs) did not differ between AW and wire-based ADR (12% vs. 15.1%, p = 0.106); both AW and wire-based ADR procedures were associated with significant symptom improvements.
CONCLUSIONS
As compared to AW, wire-based ADR is a reliable and effective strategy successfully used in more complex lesions and often after the failure of other techniques. At long-term follow-up, patient's MACCEs and symptoms improvement were similar in both antegrade techniques.

Identifiants

pubmed: 37668012
doi: 10.1002/ccd.30827
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

864-877

Informations de copyright

© 2023 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals LLC.

Références

Suzuki Y, Tsuchikane E, Katoh O, et al. Outcomes of percutaneous coronary interventions for chronic total occlusion performed by highly experienced Japanese specialists: The first report from the Japanese CTO-PCI Expert Registry. JACC Cardiovasc Interv. 2017;10(21):2144-2154. doi:10.1016/j.jcin.2017.06.024
Tajti P, Karmpaliotis D, Alaswad K, et al. The hybrid approach to chronic total occlusion percutaneous coronary intervention. JACC Cardiovasc Interv. 2018;11(14):1325-1335. doi:10.1016/j.jcin.2018.02.036
Konstantinidis NV, Werner GS, Deftereos S, et al. Temporal trends in chronic total occlusion interventions in Europe. Circ Cardiovasc Interv. 2018;11(10):e006229. doi:10.1161/CIRCINTERVENTIONS.117.006229
Harding SA, Wu EB, Lo S, et al. A new algorithm for crossing chronic total occlusions from the Asia Pacific Chronic Total Occlusion Club. JACC Cardiovasc Interv. 2017;10(21):2135-2143. doi:10.1016/j.jcin.2017.06.071
Brilakis ES, Mashayekhi K, Tsuchikane E, et al. Guiding principles for chronic total occlusion percutaneous coronary intervention. Circulation. 2019;140(5):420-433. doi:10.1161/CIRCULATIONAHA.119.039797
Galassi AR, Werner GS, Boukhris M, et al. Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO club. EuroIntervention. 2019;15(2):198-208. doi:10.4244/EIJ-D-18-00826
Wu EB, Brilakis ES, Mashayekhi K, et al. Global chronic total occlusion crossing algorithm. J Am Coll Cardiol. 2021;78(8):840-853. doi:10.1016/j.jacc.2021.05.055
Colombo A, Mikhail GW, Michev I, et al. Treating chronic total occlusions using subintimal tracking and reentry: the STAR technique. Catheter Cardiovasc Interv. 2005;64(4):407-411. doi:10.1002/ccd.20307
Carlino M, Godino C, Latib A, Moses JW, Colombo A. Subintimal tracking and re-entry technique with contrast guidanc: A safer approach. Catheter Cardiovasc Interv. 2008;72(6):790-796. doi:10.1002/ccd.21699
Erratum in: Catheter Cardiovasc Interv. 2009 Jan 1;73(1):127.
Michael TT, Papayannis AC, Banerjee S, Brilakis ES. Subintimal dissection/reentry strategies in coronary chronic total occlusion interventions. Circ Cardiovasc Interv. 2012;5(5):729-738. doi:10.1161/CIRCINTERVENTIONS.112.969808
Galassi AR, Tomasello SD, Costanzo L, et al. Mini-STAR as bail-out strategy for percutaneous coronary intervention of chronic total occlusion. Catheter Cardiovasc Interv. 2012;79(1):30-40. doi:10.1002/ccd.22998
Galassi AR, Boukhris M, Tomasello SD, et al. Long-term clinical and angiographic outcomes of the mini-STAR technique as a bailout strategy for percutaneous coronary intervention of chronic total occlusion. Can J Cardiol. 2014;30(11):1400-1406. doi:10.1016/j.cjca.2014.07.016
Azzalini L, Carlino M, Brilakis ES, et al. Subadventitial techniques for chronic total occlusion percutaneous coronary intervention: the concept of “vessel architecture. Catheter Cardiovasc Interv. 2018;91(4):725-734. doi:10.1002/ccd.27025
Azzalini L, Alaswad K, Uretsky BF, et al. Multicenter experience with the antegrade fenestration and reentry technique for chronic total occlusion recanalization. Catheter Cardiovasc Interv. 2021;97(1):E40-E50. doi:10.1002/ccd.28941
Ybarra LF, Rinfret S, Brilakis ES, et al. Definitions and clinical trial design principles for coronary artery chronic total occlusion therapies: CTO-ARC consensus recommendations. Circulation. 2021;143(5):479-500. doi:10.1161/CIRCULATIONAHA.120.046754
Galassi AR, Sianos G, Werner GS, et al. Retrograde recanalization of chronic total occlusions in Europe. J Am Coll Cardiol. 2015;65(22):2388-2400. doi:10.1016/j.jacc.2015.03.566
Abdalwahab A, Farag M, Brilakis ES, Galassi AR, Egred M. Management of coronary artery perforation. Cardiovasc Revasc Med. 2021;26:55-60. doi:10.1016/j.carrev.2020.11.013
Mehran R, Dangas GD, Weisbord SD. Contrast-associetaed acute kidney injury. NEJM. 2019;30(380):2146-2155.
Morino Y, Abe M, Morimoto T, et al. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes. JACC Cardiovasc Interv. 2011;4(2):213-221. doi:10.1016/j.jcin.2010.09.024
Christopoulos G, Kandzari DE, Yeh RW, et al. Development and validation of a novel scoring system for predicting technical success of chronic total occlusion percutaneous coronary interventions. JACC Cardiovasc Interv. 2016;9(1):1-9. doi:10.1016/j.jcin.2015.09.022
Szijgyarto Z, Rampat R, Werner GS, et al. Derivation and validation of a chronic total coronary occlusion intervention procedural success score from the 20,000-Patient EuroCTO Registry. JACC Cardiovasc Interv. 2019;12(4):335-342. doi:10.1016/j.jcin.2018.11.020
Azzalini L, Dautov R, Brilakis ES, et al. Procedural and longer-term outcomes of wire- versus device-based antegrade dissection and re-entry techniques for the percutaneous revascularization of coronary chronic total occlusions. Int J Cardiol. 2017;231:78-83. doi:10.1016/j.ijcard.2016.11.273
Srivatsa SS, Edwards WD, Boos CM, et al. Histologic correlates of angiographic chronic total coronary artery occlusions. J Am Coll Cardiol. 1997;29(5):955-963. doi:10.1016/s0735-1097(97)00035-1
Katsuragawa M, Fujiwara H, Miyamae M, Sasayama S. Histologic studies in percutaneous transluminal coronary angioplasty for chronic total occlusion: comparison of tapering and abrupt types of occlusion and short and long occluded segments. J Am Coll Cardiol. 1993;21:604-611.
Munce NR, Strauss BH, Qi X, et al. Intravascular and extravascular microvessel formation in chronic total occlusions. JACC Cardiovasc Imaging. 2010;3(8):797-805. doi:10.1016/j.jcmg.2010.03.013
Strauss BH, Segev A, Wright GA, et al. Microvessels in chronic total occlusions: pathways for successful guidewire crossing? J Interv Cardiol. 2005;18(6):425-436. doi:10.1111/j.1540-8183.2005.00082.x
Brilakis ES, Grantham JA, Rinfret S, et al. A percutaneous treatment algorithm for crossing coronary chronic total occlusions. JACC Cardiovasc Interv. 2012;5(4):367-379. doi:10.1016/j.jcin.2012.02.006
Chan CY, Wu EB, Yan BP, Tsuchikane E. Procedure failure of chronic total occlusion percutaneous coronary intervention in an algorithm driven contemporary Asia-Pacific Chronic Total Occlusion Club (APCTO Club) multicenter registry. Catheter Cardiovasc Interv. 2019;93(6):1033-1038.
Tanaka H, Tsuchikane E, Muramatsu T, et al. A novel algorithm for treating chronic total coronary artery occlusion. J Am Coll Cardiol. 2019;74(19):2392-2404. doi:10.1016/j.jacc.2019.08.1049
Maeremans J, Walsh S, Knaapen P, et al. The hybrid algorithm for treating Chronic Total occlusions in Europe. J Am Coll Cardiol. 2016;68(18):1958-1970. doi:10.1016/j.jacc.2016.08.034
Wilson WM, Walsh SJ, Yan AT, et al. Hybrid approach improves success of chronic total occlusion angioplasty. Heart. 2016;102(18):1486-1493. doi:10.1136/heartjnl-2015-308891
Wilson WM, Walsh SJ, Bagnall A, et al. One-year outcomes after successful chronic total occlusion percutaneous coronary intervention: the impact of dissection re-entry techniques. Catheter Cardiovasc Interv. 2017;90(5):703-712. doi:10.1002/ccd.26980
Rinfret S, Ribeiro HB, Nguyen CM, Nombela-Franco L, Ureña M, Rodés-Cabau J. Dissection and re-entry techniques and longer-term outcomes following successful percutaneous coronary intervention of chronic total occlusion. Am J Cardiol. 2014;114(9):1354-1360. doi:10.1016/j.amjcard.2014.07.067
Simsek B, Kostantinis S, Karacsonyi J, et al. Predicting periprocedural complications in chronic total occlusion percutaneous coronary intervention. JACC Cardiovasc Interv. 2022;15(14):1413-1422. doi:10.1016/j.jcin.2022.06.007
Erratum in: JACC Cardiovasc Interv. 2022 Dec 12;15(23):2461.

Auteurs

Alfredo R Galassi (AR)

Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.

Giuseppe Vadalà (G)

Division of Cardiology, University Hospital "P. Giaccone", Palermo, Italy.

Laura Maniscalco (L)

Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.

Gabriele Gasparini (G)

Department of Invasive Cardiology, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.

Dens Jo (D)

Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.

Nenad Z Bozinovic (NZ)

University Clinical Niš, Niš, Serbia.

Sevket Gorgulu (S)

Cardiology Department, Acıbadem University Medical Faculty, Istanbul, Turkey.

Thomas Gehrig (T)

Duke University, Durham, North Carolina, USA.

Luca Grancini (L)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Imre Ungi (I)

Second Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.

Eugenio La Scala (E)

Polyclinique Les Fleur, Ollioules, France.

Andrew Ladwiniec (A)

Department of Cardiovascular Sciences and the NIHR Leicester Biomedical Research Centre, Glenfield Hospital, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, UK.

Sinisa Stojkovic (S)

Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
mDepartment of Cardiology, Clinical Center of Serbia, Beograd, Belgrade, Serbia.

Alessio La Manna (A)

Cardio-Thoracic-Vascular Department, Azienda Ospedaliero-Universitaria "Policlinico-Vittorio Emanuele", University of Catania, Catania, Italy.

Carlo Tumscitz (C)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, Ferrara, Italy.

Simon Elhadad (S)

Department of Cardiology, CH Marne La Vallée, Jossigny, France.

Gerald S Werner (GS)

Medizinische Klinik I, Klinikum Darmstadt, Darmstadt, Germany.

Georgios Sianos (G)

1st Cardiology Department, AHEPA University Hospital, Thessaloniki, Greece.

Roberto Garbo (R)

nterventional Cardiology Department, Maria Pia Hospital, GVM Care and Research, Turin, Italy.

Mauro Carlino (M)

Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy.

Kambis Mashayekhi (K)

Division of Cardiology and Angiology II, University Heart Center Freiburg-Bad Krozingen, Bad Krozingen, Germany.

Carlo di Mario (C)

Department of Clinical & Experimental Medicine, Structural Interventional Cardiology Division, Careggi University Hospital, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH